140 results
Page 2 of 7
424B5
tfpwt 6zr6wiob
26 Jan 21
Prospectus supplement for primary offering
5:11pm
424B5
0arpl89y
25 Jan 21
Prospectus supplement for primary offering
4:16pm
8-K
EX-10.1
uxwwtmulsmmnbuye
9 Sep 20
Seelos Therapeutics Announces Closing of $7.0 Million Registered Direct Offering
4:02pm
8-K
EX-1.1
uz7yl
12 Mar 20
Seelos Therapeutics Announces Pricing of $4.5 Million Public Offering of Common Stock
5:24pm
424B4
0xtq0ql
11 Feb 20
Prospectus supplement with pricing info
5:14pm
8-K
EX-1.1
4zlun6m9
11 Feb 20
Seelos Therapeutics Announces Pricing of $5 Million Public Offering of Common Stock
6:08am
8-K
EX-10.1
p1obzjd5jj2okmo 77c
27 Aug 19
Entry into a Material Definitive Agreement
4:31pm
8-K
EX-1.1
btqni2ik5bib
17 Jun 19
Entry into a Material Definitive Agreement
9:55pm
8-K
EX-10.2
n25ubkn7717k410zkxgi
26 Mar 19
Departure of Directors or Certain Officers
4:55pm
8-K
EX-2.1
gs5be0
19 Feb 19
Seelos Therapeutics Completes Acquisition of Trehalose from Bioblast Pharma
8:00am
424B3
coehyzdvqdzg pac
20 Nov 18
Prospectus supplement
4:09pm